ACIU Relative Valuation - AC Immune SA - Alpha Spread

AC Immune SA
NASDAQ:ACIU

Watchlist Manager
AC Immune SA Logo
AC Immune SA
NASDAQ:ACIU
Watchlist
Price: 3.31 USD -2.65% Market Closed
Market Cap: 327.5m USD
Have any thoughts about
AC Immune SA?
Write Note

Relative Value

The Relative Value of one ACIU stock under the Base Case scenario is 9.69 USD. Compared to the current market price of 3.31 USD, AC Immune SA is Undervalued by 66%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ACIU Relative Value
Base Case
9.69 USD
Undervaluation 66%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
52
vs Industry
31
Median 3Y
22.8
Median 5Y
20.8
Industry
8.1
Forward
42.3
vs History
vs Industry
Median 3Y
-3.9
Median 5Y
-4.5
Industry
25.2
Forward
-3.5
vs History
12
vs Industry
Median 3Y
-3.6
Median 5Y
-4.1
Industry
23.2
vs History
4
vs Industry
Median 3Y
-4.4
Median 5Y
-4.9
Industry
26.9
vs History
19
vs Industry
42
Median 3Y
1.6
Median 5Y
1.7
Industry
2.6
vs History
50
vs Industry
33
Median 3Y
11.5
Median 5Y
8.5
Industry
7.7
Forward
16.4
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.3
vs History
vs Industry
Median 3Y
-2
Median 5Y
-2
Industry
5
Forward
9.4
vs History
vs Industry
Median 3Y
-1.9
Median 5Y
-2
Industry
4.6
Forward
-2.9
vs History
11
vs Industry
Median 3Y
-1.8
Median 5Y
-2
Industry
6.8
vs History
11
vs Industry
Median 3Y
-1.8
Median 5Y
-2
Industry
4.3
vs History
76
vs Industry
38
Median 3Y
2.1
Median 5Y
3
Industry
4.8

Multiples Across Competitors

ACIU Competitors Multiples
AC Immune SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
AC Immune SA
NASDAQ:ACIU
328.3m USD 18.2 -4.7 -1.9 -1.8
US
Abbvie Inc
NYSE:ABBV
340.8B USD 6.2 64.3 15.7 24.1
US
Amgen Inc
NASDAQ:AMGN
170.7B USD 5.5 54.5 19.3 35
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.4B USD 11.5 -241.7 25.7 26.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
111.7B USD 8.3 25.8 22.5 24.9
US
Gilead Sciences Inc
NASDAQ:GILD
106.2B USD 3.8 100.8 9.6 12.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 948.5 -497.2 -541.4 -527
AU
CSL Ltd
ASX:CSL
141.4B AUD 6.4 36.1 22.1 27.5
US
Seagen Inc
F:SGT
39.3B EUR 18.8 -57.6 -61.9 -55.9
KY
Beigene Ltd
SSE:688235
261.2B CNY 11.8 -59.7 -37.2 -37.2
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
34.7B USD 14.8 -476.3 209.5 322.5
P/E Multiple
Earnings Growth
CH
AC Immune SA
NASDAQ:ACIU
Average P/E: 56.3
Negative Multiple: -4.7
N/A
US
Abbvie Inc
NYSE:ABBV
64.3
406%
US
Amgen Inc
NASDAQ:AMGN
54.5
74%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.7
38%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
25.8
56%
US
Gilead Sciences Inc
NASDAQ:GILD
100.8
71%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -497.2 N/A
AU
CSL Ltd
ASX:CSL
36.1
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.6 N/A
KY
Beigene Ltd
SSE:688235
Negative Multiple: -59.7 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -476.3 N/A
EV/EBITDA Multiple
EBITDA Growth
CH
AC Immune SA
NASDAQ:ACIU
Average EV/EBITDA: 46.3
Negative Multiple: -1.9
N/A
US
Abbvie Inc
NYSE:ABBV
15.7
28%
US
Amgen Inc
NASDAQ:AMGN
19.3
64%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.7
37%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
22.5
53%
US
Gilead Sciences Inc
NASDAQ:GILD
9.6
9%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -541.4 N/A
AU
CSL Ltd
ASX:CSL
22.1
42%
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.9 N/A
KY
Beigene Ltd
SSE:688235
Negative Multiple: -37.2 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
209.5
N/A
EV/EBIT Multiple
EBIT Growth
CH
AC Immune SA
NASDAQ:ACIU
Average EV/EBIT: 67.6
Negative Multiple: -1.8
N/A
US
Abbvie Inc
NYSE:ABBV
24.1
86%
US
Amgen Inc
NASDAQ:AMGN
35
95%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.9
38%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
24.9
49%
US
Gilead Sciences Inc
NASDAQ:GILD
12.1
26%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -527 N/A
AU
CSL Ltd
ASX:CSL
27.5
59%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.9 N/A
KY
Beigene Ltd
SSE:688235
Negative Multiple: -37.2 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
322.5
N/A

See Also

Discover More
Back to Top